3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
5
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Colonic Neoplasms
11
Rectal Neoplasms
9
Colorectal Neoplasms
9
Stomach Neoplasms
5
Liver Neoplasms
5
Esophageal Neoplasms
5
Pancreatic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Small Cell Lung Carcinoma
3
Precancerous Conditions
3
Carcinoma, Ovarian Epithelial
3
Breast Neoplasms
3
Sarcoma
2
Salivary Gland Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Nasopharyngeal Neoplasms
2
Mouth Neoplasms
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Laryngeal Neoplasms
2
Kidney Neoplasms
2
Hypopharyngeal Neoplasms
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Gallbladder Neoplasms
2
Fallopian Tube Neoplasms
2
Interventions
pembrolizumab
50
Cyclophosphamide
25
Carboplatin
25
Gemcitabine
20
Cisplatin
19
fludarabine
18
Nivolumab
17
Paclitaxel
16
Bevacizumab
15
Specimen Handling
14
Fluorouracil
11
Magnetic Resonance Spectroscopy
10
aldesleukin
9
Oxaliplatin
9
Irinotecan
9
Docetaxel
9
Biopsy
9
olaparib
8
Trastuzumab
8
durvalumab
7
atezolizumab
7
Hyperthermic Intraperitoneal Chemotherapy
7
Albumin-Bound Paclitaxel
7
Taxes
6
Leucovorin
6
Ipilimumab
6
Interleukin-2
6
Cetuximab
6
Capecitabine
6
130-nm albumin-bound paclitaxel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Polymerase Chain Reaction
×
Gastrointestinal
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled